Daewoong Co., Ltd. (KRX: 003090)

Market Cap	834.17B
Revenue (ttm)	1.88T
Net Income (ttm)	123.36B
Shares Out	40.89M
EPS (ttm)	3,024.94
PE Ratio	6.74
Forward PE	7.31
Dividend	100.00 (0.49%)
Ex-Dividend Date	Dec 27, 2024

Volume	43,635
Open	20,300
Previous Close	20,500
Day's Range	19,970 - 20,400
52-Week Range	15,050 - 28,100
Beta	1.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 356
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2023, Daewoong's revenue was 1.81 trillion, an increase of 6.86% compared to the previous year's 1.70 trillion. Earnings were 152.67 billion, an increase of 48.85%.